Skip to content

Clinical trials

Phase 3 Failure to Thrive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Failure to Thrive Phase: Phase 3 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20091
20111
20151
20161
20172
20201
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ascendis Pharma Endocrinology Division A/S3
Ascendis Pharma A/S2
Tampere University2
Eli Lilly and Company1
Ipsen1
Northwell Health1
Versartis Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Failure to Thrive11
Dwarfism, Pituitary5
Endocrine System Diseases5
Growth Disorders4
Pituitary Diseases4
Dwarfism2
Malnutrition2
Turner Syndrome2
Chromosome Disorders1
Infant Nutrition Disorders1

Trials

Showing 76 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.